Close Menu

NEW YORK (GenomeWeb) – Guardant Health this week opened its Asia, Middle East, and Africa headquarters in Singapore, which it said will scale commercialization of the firm's Guardant360 liquid biopsy assay in the region. It is currently offering the test to clinical customers in the region to assist with treatment selection for patients with advanced cancers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.